BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9568453)

  • 1. Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison. The NETWORK Investigators.
    Eur Heart J; 1998 Mar; 19(3):481-9. PubMed ID: 9568453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure.
    Pacher R; Stanek B; Globits S; Berger R; Hülsmann M; Wutte M; Frey B; Schuller M; Hartter E; Ogris E
    Eur Heart J; 1996 Aug; 17(8):1223-32. PubMed ID: 8869864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter study. High Enalapril Dose Study Group.
    Nanas JN; Alexopoulos G; Anastasiou-Nana MI; Karidis K; Tirologos A; Zobolos S; Pirgakis V; Anthopoulos L; Sideris D; Stamatelopoulos SF; Moulopoulos SD
    J Am Coll Cardiol; 2000 Dec; 36(7):2090-5. PubMed ID: 11127445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial.
    Lam PH; Dooley DJ; Fonarow GC; Butler J; Bhatt DL; Filippatos GS; Deedwania P; Forman DE; White M; Fletcher RD; Arundel C; Blackman MR; Adamopoulos C; Kanonidis IE; Aban IB; Patel K; Aronow WS; Allman RM; Anker SD; Pitt B; Ahmed A
    Eur J Heart Fail; 2018 Feb; 20(2):359-369. PubMed ID: 28980368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure: a comparison of enalapril and perindopril. Slovak Investigator Group.
    Vítovec J; Spinar J
    Eur J Heart Fail; 2000 Sep; 2(3):299-304. PubMed ID: 10938492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Within-patient comparison of effects of different dosages of enalapril on functional capacity and neurohormone levels in patients with chronic heart failure.
    Brunner-La Rocca HP; Weilenmann D; Kiowski W; Maly FE; Candinas R; Follath F
    Am Heart J; 1999 Oct; 138(4 Pt 1):654-62. PubMed ID: 10502210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failure.
    Tang WH; Vagelos RH; Yee YG; Benedict CR; Willson K; Liss CL; Fowler MB
    J Am Coll Cardiol; 2002 Jan; 39(1):70-8. PubMed ID: 11755289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the safety and efficacy of delapril with enalapril in patients with congestive heart failure.
    Rengo F; Acanfora D; Furgi G; Papa A; Nicolino A; Picone C; Vitale DF; Rengo C
    Am J Cardiol; 1995 Jun; 75(18):25F-28F. PubMed ID: 7778530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure.
    Luzier AB; Forrest A; Adelman M; Hawari FI; Schentag JJ; Izzo JL
    Am J Cardiol; 1998 Aug; 82(4):465-9. PubMed ID: 9723634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
    Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
    Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect on mode of death of heart failure treatment started with bisoprolol followed by Enalapril, compared to the opposite order: results of the randomized CIBIS III trial.
    Krum H; van Veldhuisen DJ; Funck-Brentano C; Vanoli E; Silke B; Erdmann E; Follath F; Ponikowski P; Goulder M; Meyer W; Lechat P; Willenheimer R;
    Cardiovasc Ther; 2011 Apr; 29(2):89-98. PubMed ID: 20528880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacogenomic control of angiotensin converting enzyme gene I/D polymorphism predominant risk factor of development of chronic heart failure and target of enalapril treatment].
    Tepliakov AT; Shilov SN; Berezikova EN; Efremov AV; Safronov ID; Pustovetova MG; Maianskaia SD; Torim IuIu; Karpov RS
    Kardiologiia; 2013; 53(3):9-14. PubMed ID: 23548421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurohormonal activation and congestive heart failure: today's experience with ACE inhibitors and rationale for their use.
    Sigurdsson A; Swedberg K
    Eur Heart J; 1995 Dec; 16 Suppl N():65-72. PubMed ID: 8682064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of beta 1 blockade with atenolol on progression of heart failure in patients pretreated with high-dose enalapril.
    Sturm B; Pacher R; Strametz-Juranek J; Berger R; Frey B; Stanek B
    Eur J Heart Fail; 2000 Dec; 2(4):407-12. PubMed ID: 11113718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
    MacFadyen RJ; Lees KR; Reid JL
    Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE inhibitor dosage at the time of listing predicts survival.
    Berger R; Kuchling G; Frey B; Kozanly I; Pacher R; Stanek B
    J Heart Lung Transplant; 2000 Feb; 19(2):127-33. PubMed ID: 10703687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE inhibitors in heart failure--switching from enalapril to perindopril.
    Masuell M; Brusca G; Pardo A; Piñeiro D; Checkerdhemian S; Forcada P
    Curr Med Res Opin; 2002; 18(5):296-302. PubMed ID: 12240792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN).
    Remme WJ; Riegger G; Hildebrandt P; Komajda M; Jaarsma W; Bobbio M; Soler-Soler J; Scherhag A; Lutiger B; Rydén L
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):57-66. PubMed ID: 15115904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of angiotensin-converting enzyme inhibitor prescriptions, educational interventions, and outcomes among hospitalized patients with heart failure.
    McDermott MM; Lee P; Mehta S; Gheorghiade M
    Clin Cardiol; 1998 Apr; 21(4):261-8. PubMed ID: 9562936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial.
    Kristensen SL; Mogensen UM; Tarnesby G; Gimpelewicz CR; Ali MA; Shao Q; Chiang Y; Jhund PS; Abraham WT; Dickstein K; McMurray JJV; Køber L
    Eur J Heart Fail; 2018 Jan; 20(1):136-147. PubMed ID: 28948656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.